Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab

J Allergy Clin Immunol. 2009 Mar;123(3):704-5. doi: 10.1016/j.jaci.2008.11.035. Epub 2009 Jan 18.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Anti-Allergic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Autoantibodies / blood
  • Autoantibodies / immunology*
  • Autoantigens / immunology
  • Autoantigens / metabolism
  • Autoimmunity / immunology*
  • Collagen Type XVII
  • Female
  • Humans
  • Immunoglobulin E / blood
  • Immunoglobulin E / immunology*
  • Non-Fibrillar Collagens / immunology
  • Non-Fibrillar Collagens / metabolism
  • Omalizumab
  • Pemphigoid, Bullous / drug therapy*
  • Pemphigoid, Bullous / immunology
  • Pemphigoid, Bullous / pathology

Substances

  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Autoantibodies
  • Autoantigens
  • Non-Fibrillar Collagens
  • Omalizumab
  • Immunoglobulin E